# Method Verification Protocol for Diagnostic Assays ## Quick Answer - Verify commercial diagnostic assays through a structured protocol that measures precision, accuracy, analytical sensitivity, and analytical specificity against manufacturer claims. - Run a minimum of 20 replicates across at least three runs using known positive and negative controls before reporting assay performance as verified. - Verification confirms performance under your conditions, but it does not replace full validation for novel targets or regulatory submissions. ## Purpose and Scope of Method Verification Method verification is the process of confirming that a commercial diagnostic assay performs according to the manufacturer's stated specifications when used in a specific laboratory. This process differs from method validation, which establishes performance characteristics for a newly developed assay. Verification applies to assays that have already been validated by the manufacturer and are being introduced into a new testing environment. The verification protocol described here applies to molecular diagnostic assays including PCR-based tests, isothermal amplification methods, and hybridization-based detection systems. The protocol focuses on the practical steps a laboratory must complete before reporting patient or research results. The core question is whether the assay produces reliable results when operated by your staff, using your equipment, and with your sample handling procedures. Laboratories adopt verification protocols to meet accreditation requirements, satisfy regulatory expectations, and protect the integrity of diagnostic results. The National Institute of Standards and Technology emphasizes that measurement science depends on traceable standards and documented procedures. When you verify an assay, you establish that your measurement system produces results consistent with the manufacturer's claims. This documentation becomes part of your laboratory's quality system and provides evidence for audits and inspections. The scope of verification includes the analytical phase of testing. Pre-analytical factors such as specimen collection, transport, and storage are typically covered by separate procedures. Post-analytical factors including result interpretation and reporting are also outside the verification protocol, though the protocol should include criteria for identifying results that require further investigation. ## Regulatory and Accreditation Context Laboratories in the United States operate under oversight from multiple organizations depending on the type of testing performed. Clinical laboratories that report patient results must comply with the Clinical Laboratory Improvement Amendments administered by the Centers for Medicare and Medicaid Services. Research laboratories follow institutional policies and may be subject to additional requirements from funding agencies or institutional review boards. The National Institutes of Health provides guidelines for research involving recombinant or synthetic nucleic acid molecules. These guidelines establish oversight requirements for experiments that involve the construction and propagation of recombinant DNA. When you verify a diagnostic assay that uses recombinant materials, you must confirm that your laboratory has the appropriate approvals and follows the containment practices described in the guidelines. Biosafety considerations are part of the verification process. The Biosafety in Microbiological and Biomedical Laboratories manual from the CDC and NIH describes risk assessment principles and containment levels for work with infectious agents. Before you begin verification, you must determine the biosafety level appropriate for the specimens and controls you will handle. This determination affects the physical facilities, safety equipment, and practices required for the verification work. The National Library of Medicine provides access to molecular biology methods and laboratory procedures that support the technical aspects of verification. These resources describe the principles of nucleic acid extraction, amplification, and detection that form the basis of commercial assays. Understanding these principles helps you identify potential sources of error during verification. ## Core Principles of Assay Verification ### Analytical Sensitivity Analytical sensitivity describes the smallest amount of target that the assay can reliably detect. This is often expressed as the limit of detection. The manufacturer provides a claimed limit of detection based on their validation studies. Your verification must confirm that your laboratory can achieve this limit. To verify analytical sensitivity, you test a dilution series of a known positive sample. The dilution series should bracket the manufacturer's claimed limit of detection. You test each dilution in replicates to determine the concentration at which the assay detects the target in a specified percentage of replicates. The observed limit of detection should be equal to or better than the manufacturer's claim. The choice of sample matrix matters for sensitivity verification. A purified nucleic acid sample may not reflect the performance of the assay with clinical specimens. If the manufacturer's claim is based on testing in a specific matrix, you should use a similar matrix for your verification. This may require spiking known quantities of the target into a negative clinical matrix. ### Analytical Specificity Analytical specificity describes the ability of the assay to detect the intended target without detecting closely related organisms or substances. The manufacturer provides information about the specificity of the assay based on testing against a panel of potential cross-reactants. Your verification must confirm that the assay does not produce false positive results with the specimens you will test. Specificity verification involves testing samples that contain organisms or substances that could potentially cross-react with the assay. The manufacturer's package insert lists the organisms tested during validation. You should test a representative subset of these organisms, focusing on those most likely to be present in your patient population. The specificity panel should include negative samples that are known to be free of the target. These samples should be processed through the entire workflow from extraction to detection. A false positive result in any of these samples indicates a specificity problem that requires investigation. ### Precision Precision describes the agreement between repeated measurements of the same sample. The manufacturer provides precision data based on their validation studies. Your verification must confirm that the assay produces consistent results when run by your laboratory. Precision is evaluated at multiple levels. Within-run precision measures the variation between replicates in a single run. Between-run precision measures the variation between runs performed on different days. Between-operator precision measures the variation between different laboratory personnel performing the assay. The precision evaluation uses samples at different concentrations. The manufacturer typically provides precision data at the limit of detection and at a higher concentration. Your verification should include samples at both levels to confirm that the assay performs consistently across the reportable range. ### Accuracy Accuracy describes the agreement between the assay result and the true value of the analyte. For diagnostic assays, accuracy is often evaluated by comparing the assay results to a reference method or to a panel of characterized samples. The manufacturer provides accuracy data based on their validation studies. Your verification should include a comparison of the assay results to a reference method if one is available. The reference method may be a different assay that has been validated for the same target or a sequencing-based method. The comparison should include samples that span the reportable range of the assay. The accuracy evaluation should include samples that are positive and negative for the target. The results are used to calculate the agreement between the assay and the reference method. Discrepant results require investigation to determine whether the discrepancy is due to the assay, the reference method, or the sample. ## At a Glance | Verification Parameter | Minimum Sample Size | Acceptance Criterion | Documentation Required | | --- | --- | --- | --- | | Analytical sensitivity | 20 replicates at claimed limit of detection | Detection in at least 95% of replicates | Dilution series records, replicate results | | Analytical specificity | 20 negative samples and 10 cross-reactants | No false positive results | Sample list, extraction records, detection results | | Precision | 20 replicates across 3 runs | Coefficient of variation within manufacturer claim | Run records, operator logs, calculated statistics | ## Pre-Verification Planning ### Review the Manufacturer Documentation The manufacturer package insert is the primary source of information for the verification protocol. It describes the intended use of the assay, the performance characteristics, the required equipment and supplies, and the limitations. You must read this document carefully before you begin verification. The package insert provides the claimed performance characteristics that you will verify. These include the limit of detection, the specificity panel, the precision data, and the reportable range. You should record these claims in your verification plan so that you can compare your results to the manufacturer's data. The package insert also describes the controls that must be included in each run. These controls include a positive control, a negative control, and an internal control. The internal control monitors the extraction and amplification steps to detect inhibition or processing failures. You must include these controls in your verification runs. ### Assess Laboratory Readiness The verification protocol requires that your laboratory has the necessary equipment, reagents, and personnel. The equipment must be calibrated and maintained according to the manufacturer's recommendations. The reagents must be stored under the conditions specified by the manufacturer and must not be past their expiration dates. The laboratory personnel who will perform the verification must be trained in the assay procedure. The training should include the specimen handling, the extraction procedure, the amplification setup, and the interpretation of results. The training should be documented in the personnel records. The laboratory must have the appropriate biosafety measures in place for the specimens and reagents used in the verification. The Biosafety in Microbiological and Biomedical Laboratories describes the containment levels and practices required for work with infectious materials. You must confirm that your laboratory meets the requirements for the biosafety level appropriate for your work. ### Prepare the Verification Plan The verification plan is a written document that describes the steps you will take to verify the assay. The plan should include the following elements: - The purpose of the verification - The assay to be verified and the manufacturer's claims - The samples to be used for the verification - The number of replicates and runs - The acceptance criteria for each verification element - The personnel responsible for each step - The timeline for the verification - The documentation requirements The verification plan should be reviewed and approved by the laboratory director or the quality manager before the verification begins. The plan provides the framework for the verification and ensures that all necessary steps are included. ## Verification Workflow ### Step 1: Sample Selection and Preparation The verification samples must be selected to represent the range of results that the assay will encounter in clinical use. The samples should include positive samples at different concentrations, negative samples, and samples that may contain cross-reacting organisms. The positive samples should include samples at the manufacturer's claimed limit of detection and samples at a higher concentration. The higher concentration samples are used to verify the precision and the accuracy of the assay. The limit of detection samples are used to verify the analytical sensitivity. The negative samples should be confirmed to be free of the target. These samples are used to verify the analytical specificity and to detect any contamination in the assay. The negative samples should be processed through the same workflow as the positive samples. The cross-reacting samples should include organisms that are closely related to the target or that may be present in the same clinical specimens. The manufacturer's package insert lists the organisms tested during their validation. You should select a representative subset of these organisms for your verification. ### Step 2: Run Design and Replication The verification runs must be designed to provide sufficient data for the statistical analysis. The number of runs and the number of replicates per run depend on the verification element being evaluated. For analytical sensitivity, you should test the limit of detection samples in at least 20 replicates. The replicates should be distributed across at least three runs to account for between-run variation. The detection rate should be calculated from the total number of replicates. For precision, you should test samples at two concentrations in at least 20 replicates across at least three runs. The precision should be calculated for each concentration level. The coefficient of variation should be compared to the manufacturer's claim. For specificity, you should test the negative samples and the cross-reacting samples in at least 20 replicates. The results should be recorded for each sample. Any positive result in a negative sample or a cross-reacting sample indicates a specificity problem. ### Step 3: Data Collection and Recording The data from the verification runs must be recorded in a format that allows for the statistical analysis. The record should include the sample identification, the run number, the operator name, the date, and the result. The result should be recorded as positive, negative, or invalid. The invalid results should be investigated to determine the cause. The invalid results may be due to a failure of the internal control, a problem with the extraction, or a problem with the amplification. The investigation should be documented and the cause should be corrected before the verification continues. The data should be recorded in a laboratory notebook or an electronic data system. The record should be complete and should allow for the reconstruction of the verification. The record should be retained according to the laboratory's document retention policy. ## Statistical Analysis and Acceptance Criteria ### Calculating Detection Rates The detection rate for the analytical sensitivity is calculated by dividing the number of positive results by the total number of replicates. The detection rate should be at least 95% at the manufacturer's claimed limit of detection. If the detection rate is below 95%, the assay does not meet the manufacturer's claim in your laboratory. The detection rate should be calculated separately for each concentration level tested. The results should be recorded in the verification report. The detection rate at the limit of detection is the primary measure of analytical sensitivity. ### Calculating Precision The precision is calculated as the coefficient of variation for the replicate results. The coefficient of variation is the standard deviation divided by the mean, expressed as a percentage. The coefficient of variation should be calculated for each concentration level and for each precision level. The within-run precision is calculated from the replicates within a single run. The between-run precision is calculated from the replicates across different runs. The between-operator precision is calculated from the replicates performed by different operators. The coefficient of variation should be compared to the manufacturer's claim. If the coefficient of variation is higher than the manufacturer's claim, the assay is not performing as expected in your laboratory. The cause of the increased variation should be investigated. ### Evaluating Specificity The specificity is evaluated by the number of false positive results in the negative samples and the cross-reacting samples. The acceptance criterion is zero false positives. Any false positive result indicates a specificity problem that must be investigated. The investigation should include a review of the sample handling, the extraction procedure, and the amplification conditions. The investigation should also include a review of the reagent lots and the equipment used. The cause of the false positive should be identified and corrected before the verification continues. ### Comparing Accuracy The accuracy is evaluated by comparing the assay results to the reference method results. The comparison should include the calculation of the percent agreement, the sensitivity, and the specificity. The percent agreement is the percentage of samples for which the assay and the reference method agree. The sensitivity is the percentage of positive samples that are detected by the assay. The specificity is the percentage of negative samples that are correctly identified by the assay. The sensitivity and specificity should be compared to the manufacturer's claims. The discrepant results should be investigated to determine the cause. The investigation may include the repeat testing of the sample, the testing of the sample with a different method, or the review of the clinical information. The investigation should be documented in the verification report. ## Documentation and Record Keeping ### Verification Report The verification report is the final document that summarizes the verification results. The report should include the following sections: - The purpose of the verification - The assay and the manufacturer - The verification plan - The results of each verification element - The acceptance criteria and the comparison of the results - The conclusion of the verification - The recommendations for the implementation of the assay The verification report should be reviewed and approved by the laboratory director or the supervisor. The report should be retained in the laboratory's quality records. ### Standard Operating Procedures The verification results should be used to develop the standard operating procedures for the assay. The standard operating procedures should describe the steps for the specimen handling, the extraction, the amplification, and the detection. The standard operating procedures should also describe the interpretation of the results and the reporting of the results. The standard operating procedures should be reviewed and approved by the laboratory director. The standard operating procedures should be available to all laboratory personnel who perform the assay. The standard operating procedures should be reviewed periodically to ensure that they are current. ### Training Records The training records should document the training of the laboratory personnel who perform the assay. The training records should include the date of the training, the name of the trainer, the name of the trainee, and the content of the training. The training records should be retained in the personnel files. The training should include the hands-on practice of the assay procedure. The trainee should perform the assay under the supervision of the trainer until the trainee demonstrates proficiency. The proficiency should be documented in the training records. ## Common Failure Patterns and Troubleshooting ### Contamination Contamination is the most common cause of false positive results in molecular assays. The contamination may come from the environment, the reagents, or the equipment. The contamination may be detected by the presence of positive results in the negative controls. The prevention of contamination requires the separation of the pre-amplification and post-amplification areas. The pre-amplification area should be used for the specimen preparation and the amplification setup. The post-amplification area should be used for the amplification and the detection. The laboratory personnel should follow the procedures for the movement between the areas. The contamination should be investigated by the testing of the environment and the equipment. The investigation should include the swabbing of the surfaces and the testing of the swabs. The source of the contamination should be identified and eliminated. ### Inhibition Inhibition is the failure of the amplification reaction due to the presence of inhibitors in the sample. The inhibitors may come from the specimen matrix or from the extraction procedure. The inhibition is detected by the failure of the internal control. The inhibition may be resolved by the dilution of the sample or by the use of a different extraction method. The inhibition may also be resolved by the use of an amplification reagent that is more resistant to the inhibitors. The resolution of the inhibition should be documented in the verification report. ### Equipment Failure The equipment failure may cause the assay to produce invalid results. The equipment failure may include the failure of the thermal cycler, the failure of the detection system, or the failure of the pipettes. The equipment failure should be detected by the use of the controls. The equipment should be calibrated and maintained according to the manufacturer's recommendations. The calibration and the maintenance should be documented in the equipment records. The equipment failure should be investigated and the equipment should be repaired or replaced. ### Reagent Failure The reagent failure may cause the assay to produce invalid results. The reagent failure may include the degradation of the reagents, the contamination of the reagents, or the use of the expired reagents. The reagent failure should be detected by the use of the controls. The reagents should be stored according to the manufacturer's recommendations. The reagents should be checked for the expiration date before the use. The reagent failure should be investigated and the reagents should be replaced. ## Quality Control and Quality Assurance ### Internal Controls The internal control is a component of the assay that is used to monitor the extraction and the amplification. The internal control is added to each sample and is amplified with the target. The internal control should be detected in each sample to confirm that the extraction and the amplification were successful. The internal control failure indicates a problem with the extraction or the amplification. The sample should be repeated if the internal control fails. The cause of the internal control failure should be investigated. ### External Controls The external controls are the positive and negative controls that are included in each run. The positive control should be detected in each run to confirm that the assay is working. The negative control should not be detected in each run to confirm that there is no contamination. The external control failure should be investigated before the results of the run are reported. The run should be repeated if the external controls fail. The cause of the external control failure should be identified and corrected. ### Proficiency Testing The proficiency testing is the testing of the unknown samples that are provided by an external organization. The proficiency testing is used to evaluate the performance of the laboratory against the other laboratories. The proficiency testing should be performed on a regular basis. The proficiency testing results should be reviewed by the laboratory director. The results should be compared to the results of the other laboratories. The proficiency testing results should be used to identify the areas for the improvement. ## Biosafety and Containment Considerations ### Risk Assessment The verification of a diagnostic assay involves the handling of the biological specimens and the reagents. The risk assessment should be performed before the verification begins. The risk assessment should consider the nature of the specimens, the potential for the infectious agents, and the procedures that will be performed. The risk assessment should be documented and reviewed by the institutional biosafety committee. The risk assessment should be updated if the procedures or the specimens change. The risk assessment should be used to determine the appropriate biosafety level for the verification. ### Containment and Personal Protective Equipment The containment measures should be appropriate for the biosafety level of the work. The containment measures may include the use of the biological safety cabinet, the use of the closed containers, and the use of the appropriate personal protective equipment. The personal protective equipment may include the gloves, the lab coat, and the eye protection. The containment measures should be described in the standard operating procedures. The laboratory personnel should be trained in the use of the containment measures. The containment measures should be monitored to ensure that they are effective. ### Waste Disposal The waste from the verification should be disposed of according to the institutional policies and the regulations. The waste may include the specimens, the reagents, and the contaminated materials. The waste should be decontaminated before the disposal. The waste disposal procedures should be described in the standard operating procedures. The laboratory personnel should be trained in the waste disposal procedures. The waste disposal should be documented in the waste disposal records. ## Interpretation of Verification Results ### Comparing to the Manufacturer Claims The verification results should be compared to the manufacturer's claims for each of the performance characteristics. The comparison should be documented in the verification report. The comparison should include the observed values and the manufacturer's claims. The verification is successful if the observed values meet or exceed the manufacturer's claims. The verification is not successful if the observed values do not meet the manufacturer's claims. The laboratory should investigate the cause of the failure and the verification should be repeated. ### The Decision to Implement The decision to implement the assay should be based on the verification results. The assay should be implemented if the verification is successful. The assay should not be implemented if the verification is not successful. The implementation should include the development of the standard operating procedures, the training of the personnel, and the initiation of the quality control. The implementation should be documented in the laboratory records. ### The Limitations of the Verification The verification has limitations that should be considered when the results are interpreted. The verification is performed with a limited number of samples and may not detect all of the potential problems. The verification is performed under the conditions of the laboratory and may not reflect the performance of the assay in other laboratories. The verification does not replace the validation of the assay. The validation is performed by the manufacturer and provides the evidence of the assay performance. The verification confirms that the assay performs as claimed in the laboratory. ## Professional Escalation Criteria The verification results should be reviewed by the laboratory director. The laboratory director should be notified if the verification results do not meet the acceptance criteria. The laboratory director should be notified if the verification results indicate a problem with the assay. The laboratory director should be notified if the verification results indicate a problem with the equipment or the reagents. The laboratory director should be notified if the verification results indicate a problem with the laboratory personnel. The laboratory director should be notified if the verification results indicate a problem with the laboratory procedures. The laboratory director should be notified if the verification results indicate a problem with the biosafety. The laboratory director should be notified if the verification results indicate a problem with the quality control. The laboratory director should be notified if the verification results indicate a problem with the documentation. ## Decision Framework for Verification Outcomes The verification workflow produces data that must be translated into a clear operational decision. A structured decision framework prevents subjective interpretation and ensures that the laboratory director, quality manager, and technical staff reach consistent conclusions from the same data set. This section provides a practical framework for evaluating verification results, documenting the decision process, and determining when the assay may be implemented for routine testing. ### Classification of Verification Outcomes Each verification element should be classified independently before an overall decision is made. The classification system uses three categories: pass, conditional pass, and fail. A pass means the observed performance meets or exceeds the manufacturer's claim. A conditional pass means the observed performance falls within a defined tolerance of the manufacturer's claim but requires additional monitoring or corrective action. A fail means the observed performance does not meet the manufacturer's claim and the assay cannot be implemented until the issue is resolved. The classification should be applied to each of the four verification elements: analytical sensitivity, analytical specificity, precision, and accuracy. A separate classification for each element allows the laboratory to identify specific weaknesses instead of making a blanket judgment about the assay. The classification should be recorded in the verification report with the supporting data for each element. ### Decision Matrix for Implementation The overall decision to implement the assay should follow a predefined decision matrix. The matrix combines the classifications from each verification element into an implementation recommendation. The matrix should be established before the verification begins to prevent bias in the interpretation of results. The decision matrix has three possible outcomes. The first outcome is full implementation, which requires a pass classification for all four verification elements. The second outcome is conditional implementation, which allows the assay to be used for routine testing with specific limitations or additional monitoring requirements. The third outcome is no implementation, which requires the laboratory to repeat the verification or select a different assay. Conditional implementation may be appropriate when a single element receives a conditional pass and the other three elements receive a pass. The condition must be specific and measurable. For example, if the precision at the limit of detection exceeds the manufacturer's claim by a small margin, the laboratory may implement the assay with a requirement to repeat the precision study after a defined number of runs or after the training of additional operators. Full implementation is not permitted when any element receives a fail classification. The laboratory must investigate the cause of the failure, correct the issue, and repeat the verification for the failed element. The repeat verification must include the same sample size and acceptance criteria as the original verification. ### Documentation of the Decision The decision to implement the assay must be documented in the verification report. The documentation should include the classification for each verification element, the overall decision, the rationale for the decision, and any conditions attached to the implementation. The documentation should be signed by the laboratory director or the authorized designee. The decision documentation should also include the date of the decision and the effective date of the implementation. The effective date should be the date when the assay is first used for routine testing. The documentation should be retained in the laboratory's quality records and made available for inspection during audits. ### Monitoring After Conditional Implementation When the assay is implemented under a conditional decision, the laboratory must establish a monitoring plan. The monitoring plan should describe the additional data that will be collected, the frequency of the data collection, and the criteria for removing the condition. The monitoring plan should be documented in the verification report. The monitoring plan should include the following elements. The laboratory should track the performance of the internal and external controls for each run. The laboratory should record the results of any proficiency testing. The laboratory should track the rate of invalid results and the rate of repeat testing. The laboratory should review the monitoring data at a defined interval, typically monthly or quarterly. The condition is removed when the monitoring data demonstrate that the assay is performing consistently. The removal of the condition should be documented in the laboratory records. If the monitoring data show that the assay is not performing consistently, the laboratory should escalate the issue to the laboratory director and consider repeating the verification. ### Escalation Criteria for the Decision Framework The decision framework includes specific escalation criteria that require the laboratory director to be notified. The laboratory director should be notified when any verification element receives a fail classification. The laboratory director should be notified when the verification results indicate a potential problem with the assay, the equipment, the reagents, or the personnel. The laboratory director should also be notified when the verification results indicate a potential problem with the biosafety or the quality control. The laboratory director should be notified when the verification results indicate a potential problem with the documentation. The escalation should be documented in the verification report. ### Comparison of Verification Approaches The decision framework described in this section can be compared to alternative approaches for evaluating verification results. One alternative approach is a simple pass or fail decision based on the acceptance criteria. This approach is simpler but does not allow for the conditional implementation that may be appropriate when the assay is close to the manufacturer's claim. Another alternative approach is a statistical hypothesis test that compares the observed performance to the manufacturer's claim. This approach provides a formal statistical basis for the decision but requires a larger sample size and more complex analysis. The decision framework described here is more practical for the laboratory that needs to make a decision with a limited number of samples. The decision framework is also consistent with the principles of the MIQE guidelines, which emphasize the importance of transparency and the documentation of the experimental conditions. The framework requires the laboratory to document the classification of each element and the rationale for the decision. This documentation supports the interpretation of the verification results and provides a clear record for the audits. ### Practical Implementation of the Decision Framework The decision framework should be implemented as part of the verification plan. The verification plan should include the decision matrix, the classification criteria, and the escalation criteria. The verification plan should be reviewed and approved by the laboratory director before the verification begins. The laboratory personnel who perform the verification should be trained in the decision framework. The training should include the classification of the verification elements, the use of the decision matrix, and the documentation of the decision. The training should be documented in the personnel records. The decision framework should be reviewed periodically to ensure that it remains appropriate for the assay and the laboratory. The review should be documented in the laboratory records. The review should consider any changes in the assay, the equipment, the reagents, or the personnel. ### Records and Measurements for the Decision Framework The decision framework requires the following records and measurements. The verification report should include the classification of each verification element. The verification report should include the overall decision and the rationale for the decision. The verification report should include the conditions attached to the implementation. The monitoring plan should include the records of the control results, the proficiency testing results, and the invalid results. The monitoring plan should include the review of the monitoring data at the defined interval. The monitoring plan should include the removal of the condition when the monitoring data are satisfactory. The records should be retained according to the laboratory's document retention policy. The records should be available for the audits and the inspections. The records should be complete and accurate. ## Common Failure Patterns in the Decision Framework The decision framework can fail if the classification of the verification elements is not consistent. The classification should be based on the data and the acceptance criteria. The classification should not be based on the subjective judgment of the laboratory personnel. The decision framework can fail if the decision matrix is not followed. The decision matrix should be followed consistently for all verification studies. The decision matrix should not be modified during the verification without the approval of the laboratory director. The decision framework can fail if the monitoring plan is not implemented. The monitoring plan should be implemented after the conditional implementation. The monitoring plan should be reviewed at the defined interval. The monitoring plan should be updated if the conditions change. ## Professional Escalation Criteria for the Decision Framework The laboratory director should be notified when the decision framework indicates a fail classification for any verification element. The laboratory director should be notified when the decision framework indicates a conditional implementation that requires additional monitoring. The laboratory director should be notified when the monitoring plan indicates that the assay is not performing consistently. The laboratory director should be notified when the decision framework indicates a problem with the assay, the equipment, the reagents, or the personnel. The laboratory director should be notified when the decision framework indicates a problem with the biosafety or the quality control. The laboratory director should be notified when the decision framework indicates a problem with the documentation. The escalation should be documented in the verification report. The escalation should include the reason for the escalation and the actions taken. The escalation should be reviewed by the laboratory director and the actions should be documented. ## Frequently Asked Questions ### What is the difference between verification and validation? Validation establishes the performance characteristics of a new assay through the manufacturer's studies. Verification confirms that a commercial assay performs according to the manufacturer's claims when used in a specific laboratory. Validation is performed by the manufacturer, while verification is performed by the laboratory that will use the assay. ### How many samples are needed for verification? The number of samples depends on the verification element being evaluated. Analytical sensitivity requires at least 20 replicates at the claimed limit of detection. Precision requires at least 20 replicates across at least three runs. Specificity requires at least 20 negative samples and 10 cross-reacting samples. The sample size should be sufficient to provide the statistical confidence in the results. ### What are the acceptance criteria for verification? The acceptance criteria are based on the manufacturer's claims. The detection rate at the limit of detection should be at least 95%. The coefficient of variation should be within the manufacturer's claim. The specificity should be 100% with no false positives. The accuracy should be within the manufacturer's claim. ### What should be done if the verification fails? If the verification fails, the cause of the failure should be investigated. The investigation should include the review of the procedures, the equipment, the reagents, and the personnel. The cause of the failure should be identified and corrected. The verification should be repeated after the correction. ### What is the role of the internal control in verification? The internal control monitors the extraction and the amplification of each sample. The internal control should be detected in each sample to confirm that the extraction and the amplification were successful. The internal control failure indicates a problem with the extraction or the amplification. ### What is the role of the external controls in verification? The external controls are the positive and negative controls that are included in each run. The positive control confirms that the assay is working. The negative control confirms that there is no contamination. The external controls should be included in each run and the results should be recorded. ### How long does verification take? The verification timeline depends on the number of samples and the number of runs. The verification typically takes several days to complete. The timeline should be planned in advance and the verification should be scheduled to avoid the interruption of the laboratory work. ### What documentation is required for verification? The documentation includes the verification plan, the verification report, the standard operating procedures, and the training records. The documentation should be complete and accurate. The documentation should be retained according to the laboratory's document retention policy. ## Using the Evidence | Source | Best use in this topic | Important limitation | |---|---|---| | [Molecular Biology and Laboratory Methods](https://www.ncbi.nlm.nih.gov/books) | official guidance | Check the linked page for current local requirements | | [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) | official guidance | Check the linked page for current local requirements | | [NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules](https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules) | official guidance | Check the linked page for current local requirements | ## Related Diagnostic Guides - [Method Validation in Clinical Laboratories: A Practical Protocol](/knowledge/diagnostics/emerging-tech/method-validation-in-clinical-laboratories-a-practical-protocol) - [Cell Viability Assays: Choosing the Right Method for Your Experiment](/knowledge/diagnostics/emerging-tech/cell-viability-assays-choosing-the-right-method-for-your-experiment) - [Animal Biology](/blog/guides/animal-biology) ## References and Further Reading - [Molecular Biology and Laboratory Methods](https://www.ncbi.nlm.nih.gov/books). National Library of Medicine. - [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html). CDC and NIH. - [NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules](https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules). National Institutes of Health. - [Addgene Protocols](https://www.addgene.org/protocols). Addgene. - [MIQE Guidelines](https://academic.oup.com/clinchem/article/55/4/611/5631762). Clinical Chemistry. - [NIST Laboratory Programs](https://www.nist.gov/laboratories). National Institute of Standards and Technology. - [Laboratory Biosafety Manual](https://www.who.int/publications/i/item/9789240011311). World Health Organization. - [NCBI Literature Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information. - [Genome engineering using CRISPR-Cas9 system.](https://pubmed.ncbi.nlm.nih.gov/25408407). Methods in molecular biology (Clifton, N.J.), 2015. - [Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.](https://pubmed.ncbi.nlm.nih.gov/30518635). BMJ (Clinical research ed.), 2018. - [Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/39535756). JAMA dermatology, 2025. > This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.